Such deals allow Chinese firms to profit while minimising capital outlays, but also carry risks, law firm says.

PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC: MDXXF), a biotechnology company focused on the research, development, and manufacturing of LaNeo™ MDMA and novel ...

The Cocoon® (from Lonza) is a functionally closed, sterile, efficient manufacturing platform, which combined with our decentralized manufacturing strategy and rapid release testing, enables delivery ...

Thermo Fisher Scientific TMO has unveiled its latest innovation, the spectral-enabled Invitrogen Attune Xenith Flow Cytometer. The solution allows immunology and immuno-oncology researchers to ...

Summit Therapeutics said its closely tracked antibody, the first lung cancer drug to beat Merck’s Keytruda in a head-to-head ...

We came across a bullish thesis on Fulcrum Therapeutics, Inc. (FULC) on Stock Pursuit’s Substack. In this article, we will ...

The natural history of chronic hepatitis B virus (HBV) infection is driven by complex interactions among virological, host, ...

While a Trump administration decision to recompete several Tech Hub awards prompted frustration among supporters of the ...

Cannabis has been a globally important crop for millennia. While best known today as marijuana for its psychoactive ...

Cannabis has been a globally important crop for millennia. While best known today as marijuana for its psychoactive ...

Notably, the U.S.’ two primary biopharma trade groups—the Pharmaceutical Research and Manufacturers of America (PhRMA) and ...